Tariffs
Total 108 Posts
Beijing Details Trade Pact with U.S., Taps New Board for Multi-Billion-Dollar Tariff Cuts
Today, officials from China's Ministry of Commerce (MOFCOM) provided additional details regarding their view of the agreements reached with their U.S. counterparts last week, highlighting that Washington has agreed not to raise tariffs beyond the levels established last fall and outlining the use of the Board of
China Initiates Discussion on Modifying Tariff Concessions under WTO Schedules
In reaction to recent moves by the EU and the UK to invoke the tariff schedule modification provisions in GATT Article XXVIII, China has requested technical discussions at the WTO on the proper use of this procedure.
China Outlines "Preliminary Results" from Trump Visit
China's Ministry of Commerce detailed its view of a five-point consensus reached during this week’s summit between Presidents Donald Trump and Xi Jinping, signaling a commitment to reciprocal tariff reductions in order to deescalate tariff tensions and an expansion of trade in the aircraft and agricultural
U.S. Trade Court Ruling Strikes Down Section 122 "Balance-of- Payments Deficits" Tariffs
In a split opinion issued today, a two-judge majority on the U.S. Court of International Trade ruled that the surcharge imposed by the Trump administration under Section 122 of the Trade Act of 1974 is inconsistent with the requirements of that statute.
Beijing Scraps Tariffs for 20 African Nations in Major Trade Push
Today, China's Customs Tariff Commission of the State Council updated its tariff schedules, granting zero tariffs to imports from 20 African countries, effective next month.
Public Comments Come in for USITC PNTR Withdrawal Investigation
Public comments submitted in response to a U.S. International Trade Commission (USITC) investigation on the withdrawal of Permanent Normal Trade Relations (PNTR) for China show a split between supporters and opponents on the possible move.
In February, the USITC announced the PNTR withdrawal investigation. As the USITC explains, its
Trump Administration Imposes Pharmaceutical Tariffs, Impact on Chinese Imports May Be Limited in Short Term
Last week, the Trump administration imposed 100% tariffs on patented pharmaceutical products and ingredients. Imports of pharmaceuticals from China are largely generics, though, and may not feel much impact from these tariffs.